Dutch Firm TheOTCLab Gets EU MDR Approval For Dr. Yglo OTC Wart Device

Amsterdam-based TheOTCLab has received an EU CE mark for its new wart and verruca OTC freezing device Dr. Yglo. The firm plans to launch the product in Europe in Italy, Portugal, Estonia, Latvia, and Lithuania, and will separately look to take it further afield to the US and South Africa.

Amsterdam-based self-care company TheOTCLab Healthcare B.V. has received a European Union Medical Device Regulation certification for its latest OTC product, Dr. Yglo.

Describing Dr. Yglo as an innovative freeze treatment for warts and verrucas, TheOTClab scored a CE mark for the product...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Europe

More from Geography